TY - JOUR
T1 - Prediction of disease specific and overall survival in men with prostate cancer using the Decipher assay
AU - Garegnani, Luis
AU - Franco, Juan V.A.
AU - Melendi, Santiago E.
AU - Vernooij, Robin W.M.
AU - Jung, Jae Hung
AU - Hwang, Eu Chang
AU - Damen, Johanna A.A.G.
AU - Warlick, Christopher A.
AU - Coles, Bernadette
AU - Dahm, Philipp
N1 - Funding Information:
Cochrane Urology supported the authors in the development of this Cochrane Review protocol. The following people conducted the editorial process for this article: Sign-off Editor (final editorial decision): Vikram M Narayan, MD, Department of Urology, Emory University, Atlanta, Georgia; Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Jennifer Mariano, Cochrane Urology; Copy Editor (copy editing and production): Andrea Takeda, Cochrane Central Production Service; Peer-reviewers (provided comments and recommended an editorial decision): Prof Chris H Bangma MD PhD, Erasmus MC Cancer Institute, department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands (clinical/content review), Daniel Shapiro, MD, University of Wisconsin School of Medicine and Public Health, William S. Middleton Memorial Veterans Hospital (clinical/content review). Sign-off Editor (final editorial decision): Vikram M Narayan, MD, Department of Urology, Emory University, Atlanta, Georgia; Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Jennifer Mariano, Cochrane Urology; Copy Editor (copy editing and production): Andrea Takeda, Cochrane Central Production Service; Peer-reviewers (provided comments and recommended an editorial decision): Prof Chris H Bangma MD PhD, Erasmus MC Cancer Institute, department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands (clinical/content review), Daniel Shapiro, MD, University of Wisconsin School of Medicine and Public Health, William S. Middleton Memorial Veterans Hospital (clinical/content review).
Publisher Copyright:
Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2023/3/13
Y1 - 2023/3/13
N2 - Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. To determine the prognostic value of the Decipher gene assay in men with biopsy-confirmed clinically localized prostate cancer before and after receiving treatment. This objective can be framed in two questions following the population, index prognostic factor, comparator prognostic factor(s), outcome, timing, and setting (PICOTS) format as illustrated in Table 1. Table 1. Review question in PICOTS format. (Table presented.).
AB - Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. To determine the prognostic value of the Decipher gene assay in men with biopsy-confirmed clinically localized prostate cancer before and after receiving treatment. This objective can be framed in two questions following the population, index prognostic factor, comparator prognostic factor(s), outcome, timing, and setting (PICOTS) format as illustrated in Table 1. Table 1. Review question in PICOTS format. (Table presented.).
UR - http://www.scopus.com/inward/record.url?scp=85150739620&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD014746
DO - 10.1002/14651858.CD014746
M3 - Article
AN - SCOPUS:85150739620
SN - 1465-1858
VL - 2023
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 3
M1 - CD014746
ER -